🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/03/2001 | 37,90 | 39,54 | 37,43 | 37,66 | +0,00% | 5,56% | 25.354 |
| 14/03/2001 | 38,60 | 40,70 | 37,43 | 37,66 | -1,83% | 8,48% | 47.502 |
| 13/03/2001 | 37,90 | 39,77 | 37,43 | 38,37 | +0,00% | 6,17% | 97.863 |
| 12/03/2001 | 41,17 | 41,64 | 36,96 | 38,37 | -6,82% | 11,36% | 107.214 |
| 09/03/2001 | 42,81 | 43,04 | 40,24 | 41,17 | -4,35% | 6,56% | 95.004 |
| 08/03/2001 | 43,75 | 46,32 | 42,81 | 43,04 | -6,95% | 8,02% | 47.582 |
| 07/03/2001 | 46,03 | 47,26 | 44,21 | 46,26 | -0,38% | 6,61% | 38.793 |
| 06/03/2001 | 44,21 | 47,49 | 43,04 | 46,44 | +9,07% | 10,05% | 48.197 |
| 05/03/2001 | 44,68 | 44,92 | 42,34 | 42,58 | -2,15% | 5,76% | 20.251 |
| 02/03/2001 | 42,34 | 44,92 | 42,11 | 43,51 | +0,00% | 6,63% | 40.983 |
| 01/03/2001 | 42,11 | 44,80 | 41,87 | 43,51 | +2,20% | 6,94% | 35.987 |
| 28/02/2001 | 46,79 | 46,79 | 42,34 | 42,58 | +0,00% | 9,50% | 39.247 |
| 27/02/2001 | 45,62 | 45,85 | 42,34 | 42,58 | -6,43% | 7,69% | 33.102 |
| 26/02/2001 | 43,28 | 45,62 | 42,11 | 45,50 | +8,66% | 8,11% | 36.415 |
| 23/02/2001 | 40,70 | 43,51 | 40,47 | 41,87 | -1,11% | 7,47% | 114.053 |
| 22/02/2001 | 41,17 | 42,58 | 40,94 | 42,34 | +0,56% | 3,98% | 93.669 |
| 21/02/2001 | 44,97 | 46,79 | 41,41 | 42,11 | -6,74% | 11,96% | 122.042 |
| 20/02/2001 | 48,66 | 48,66 | 43,51 | 45,15 | -5,85% | 10,58% | 71.227 |
| 16/02/2001 | 48,66 | 48,89 | 47,02 | 47,96 | -1,91% | 3,85% | 28.614 |
| 15/02/2001 | 49,59 | 50,53 | 48,19 | 48,89 | -1,42% | 4,72% | 17.660 |
| 14/02/2001 | 50,06 | 50,30 | 47,26 | 49,59 | +1,92% | 6,07% | 58.937 |
| 13/02/2001 | 51,99 | 52,17 | 48,66 | 48,66 | -6,73% | 6,75% | 39.380 |
| 12/02/2001 | 48,66 | 52,40 | 48,42 | 52,17 | +1,36% | 8,17% | 56.158 |
| 09/02/2001 | 48,66 | 52,17 | 48,42 | 51,47 | +5,26% | 7,69% | 55.971 |
| 08/02/2001 | 50,65 | 51,23 | 48,66 | 48,89 | -2,79% | 5,08% | 23.511 |
| 07/02/2001 | 51,93 | 53,34 | 49,59 | 50,30 | -4,02% | 7,21% | 33.903 |
| 06/02/2001 | 49,83 | 52,40 | 48,66 | 52,40 | +5,16% | 7,51% | 53.380 |
| 05/02/2001 | 48,89 | 50,76 | 46,32 | 49,83 | +2,40% | 9,09% | 41.731 |
| 02/02/2001 | 48,07 | 49,59 | 47,96 | 48,66 | -0,95% | 3,41% | 48.464 |
| 01/02/2001 | 48,42 | 50,53 | 47,02 | 49,13 | +1,45% | 7,25% | 37.216 |